Profil

Dr. Friederike Ufer

Charité – Universitätsmedizin Berlin, Deutschland

Präsentation

12:00 CEST / Session: Treatment II: Clinical trials targeting immune dysregulation

Immunoadsorption in ME/CFS and Post-COVID ME/CFS: First Results from the IA-PACS-CFS Randomized Sham-Controlled Trial

Friederike Ufer